MRD evaluation by WT1 unfortunately presents some pitfalls: 10–15% of AML do not overexpress this marker, and WT1 sensitivity seem to be lower than other PCR methods, ranging from 1:500 to 1:2000 respectively in BM and PB [50]. This evidence concerns the gene WT1 and acute myeloid leukemia.